investorscraft@gmail.com

Intrinsic ValueZuiko Corporation (6279.T)

Previous Close¥1,005.00
Intrinsic Value
Upside potential
Previous Close
¥1,005.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Zuiko Corporation operates in the industrial machinery sector, specializing in the design, development, and manufacturing of converting machines. These machines are critical for producing hygiene products such as diapers, feminine napkins, face masks, and pet care items, serving both domestic and international markets. The company has expanded its portfolio to include used diaper recycling machines and medical equipment, positioning itself as a niche player in sustainable and healthcare-related industrial solutions. With its headquarters in Osaka, Japan, Zuiko leverages decades of expertise since its founding in 1946 to maintain a competitive edge in precision machinery. Its diversified product range caters to growing global demand for hygiene and medical products, reinforcing its market presence amid increasing environmental and health awareness. The company’s focus on innovation and sustainability aligns with broader industry trends, though it faces competition from larger industrial machinery firms.

Revenue Profitability And Efficiency

Zuiko reported revenue of JPY 19.95 billion for the fiscal year ending February 2025, reflecting its operational scale in the converting machinery market. However, the company recorded a net loss of JPY 788 million, with diluted EPS at -JPY 29.78, indicating profitability challenges. Operating cash flow stood at JPY 1.09 billion, suggesting some liquidity despite negative earnings, while capital expenditures of JPY 679 million highlight ongoing investments.

Earnings Power And Capital Efficiency

The company’s negative net income and EPS underscore pressures on earnings power, likely due to cost inefficiencies or competitive pricing. Operating cash flow remains positive, but the gap between earnings and cash generation warrants scrutiny. Zuiko’s capital efficiency is tempered by its loss-making position, though its cash reserves of JPY 15.32 billion provide a buffer for strategic adjustments.

Balance Sheet And Financial Health

Zuiko maintains a strong liquidity position with JPY 15.32 billion in cash and equivalents, offsetting its JPY 7.57 billion total debt. The balance sheet reflects a conservative leverage profile, supported by substantial cash holdings. However, the net loss raises questions about sustainable profitability and the need for operational restructuring to improve financial health over the medium term.

Growth Trends And Dividend Policy

Despite recent losses, Zuiko continues to pay a dividend of JPY 10 per share, signaling management’s commitment to shareholder returns. Growth prospects hinge on demand for hygiene and medical machinery, particularly in international markets. The company’s expansion into recycling and medical systems could drive future revenue, but profitability recovery remains a critical hurdle.

Valuation And Market Expectations

With a market cap of JPY 25.46 billion and a beta of 0.664, Zuiko is viewed as a relatively stable but niche industrial player. The negative earnings and modest dividend yield suggest muted market expectations, though its cash-rich balance sheet may attract value-oriented investors awaiting a turnaround.

Strategic Advantages And Outlook

Zuiko’s specialized machinery and sustainability-focused innovations provide strategic differentiation. The outlook depends on its ability to capitalize on global hygiene trends and improve cost management. Near-term challenges persist, but long-term potential exists if the company can align profitability with its technological and market strengths.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount